Global Immuno Oncology Market is expected to reach USD 154.57 billion by 2030, at a CAGR of 22.9% during the forecast period 2022-2030.Immuno Oncology is also known as cancer immunotherapy, which is the study of the development of a treatment that uses the body’s immune system to prevent, control, and eliminate cancer.